Operose Advisors’s iShares Russell 2000 ETF IWM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.31M Sell
17,375
-21
-0.1% -$5.42K 1% 15
2025
Q4
$4.28M Buy
17,396
+1,083
+7% +$266K 1% 15
2025
Q3
$3.95M Sell
16,313
-331
-2% -$75.9K 0.98% 14
2025
Q2
$3.59M Buy
16,644
+247
+2% +$49.7K 1.01% 13
2025
Q1
$3.27M Buy
16,397
+2,683
+20% +$582K 1.08% 11
2024
Q4
$3.03M Buy
13,714
+106
+0.8% +$24.2K 1.04% 13
2024
Q3
$3.01M Sell
13,608
-74
-0.5% -$15.8K 0.97% 13
2024
Q2
$2.78M Hold
13,682
0.98% 13
2024
Q1
$2.88M Sell
13,682
-13
-0.1% -$2.59K 0.97% 11
2023
Q4
$2.75M Buy
13,695
+1,419
+12% +$254K 1.1% 11
2023
Q3
$2.17M Buy
12,276
+12,263
+94,331% +$2.3M 0.86% 16
2023
Q2
$2.44K Sell
13
-835
-98% -$149K ﹤0.01% 329
2023
Q1
$151K Sell
848
-20
-2% -$3.68K 0.08% 90
2022
Q4
$151K Sell
868
-525
-38% -$93.4K 0.08% 89
2022
Q3
$230K Hold
1,393
0.15% 52
2022
Q2
$236K Buy
1,393
+2
+0.1% +$369 0.17% 48
2022
Q1
$286K Buy
1,391
+1
+0.1% +$204 0.2% 51
2021
Q4
$309K Buy
+1,390
New +$314K 0.25% 45

Other funds holding IWM

Operose Advisors's IWM Position: Q1 2026 in Review

Operose Advisors reduced its iShares Russell 2000 ETF (IWM) stake by 0.12% in Q1 2026, selling an estimated $5.42K and leaving 17,375 shares worth $4.31M. The position accounts for 1% of the portfolio, ranked #15.

Operose Advisors first reported a position in IWM in Q4 2021 and has held it in 18 quarters since. 2,568 funds tracked by Wall St. Rank hold IWM as of Q1 2026.

  • Operose Advisors held 17,375 shares of iShares Russell 2000 ETF worth $4.31M as of Q1 2026.
  • Operose Advisors sold 21 iShares Russell 2000 ETF shares in Q1 2026, an estimated $5.42K.
  • iShares Russell 2000 ETF made up 1% of Operose Advisors's portfolio in Q1 2026, its #15 holding.
  • Operose Advisors first reported a position in iShares Russell 2000 ETF in Q4 2021 and has held it in 18 quarters since.
  • 2,568 funds tracked by Wall St. Rank held iShares Russell 2000 ETF as of Q1 2026.

Based on Operose Advisors's 13F filing for Q1 2026, filed 12 May 2026.